Home >> WEBINARS >> Current and emerging biomarkers: science, technologies, and practicalities

Current and emerging biomarkers: science, technologies, and practicalities

Print Friendly, PDF & Email

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Webinar presenter Tabetha Sundin, PhD, HCLD, MB, Sentara Healthcare, Scientific Director, discusses advancements that may help predict which patients are likely to benefit from immuno-oncology therapies. This on-demand webinar originally broadcast on October 3, 2018.

CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a special grant from Bristol-Myers Squibb. IOUS1802863-01

x

Check Also

Procalcitonin: once is not enough.
The critical role of serial testing.

Webinar presenters Matthew Bell, Mike Broyles, PharmD, and Eric Gluck, MD, discuss current laboratory/clinical practice, how to use procalcitonin in sepsis and LRTI to determine when to start and stop antibiotic therapy, the importance of procalcitonin assay precision and sensitivity to support clinical decisions, and the impact of procalcitonin testing on antibiotic stewardship. This on-demand webinar originally broadcast on August 21, 2018.

X